The North America Alzheimer’s drugs market is witnessing significant expansion driven by the rising prevalence of neurodegenerative disorders, increasing geriatric population, and continuous advancements in pharmaceutical research. Alzheimer’s disease, a progressive neurological condition, remains the leading cause of dementia, especially across developed economies such as the...